购物车
- 全部删除
- 您的购物车当前为空
LRRK2-IN-1 是一种选择性的LRRK2有效抑制剂,作用于 LRRK2 (G2019S) 和 LRRK2 (WT),IC50值分别为 6 nM 和 13 nM。
为众多的药物研发团队赋能,
让新药发现更简单!
LRRK2-IN-1 是一种选择性的LRRK2有效抑制剂,作用于 LRRK2 (G2019S) 和 LRRK2 (WT),IC50值分别为 6 nM 和 13 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 219 | 现货 | |
5 mg | ¥ 489 | 现货 | |
10 mg | ¥ 788 | 现货 | |
25 mg | ¥ 1,570 | 现货 | |
50 mg | ¥ 2,990 | 现货 | |
100 mg | ¥ 4,390 | 现货 | |
500 mg | ¥ 9,490 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 718 | 现货 |
产品描述 | LRRK2-IN-1 is an effective and selective LRRK2 inhibitor. |
靶点活性 | DCLK2:45 nM, LRRK2 (WT):13 nM, LRRK2 (G2019S):6 nM |
体外活性 | 在稳定表达GFP-LRRK2[G2019S]的HEK 293细胞中,LRRK2-IN-1改变了LRRK2的细胞质定位。在人源神经母细胞瘤SHSY5Y细胞和小鼠Swiss 3T3细胞中,LRRK2-IN-1引起剂量依赖性的Ser910和Ser935去磷酸化以及14-3-3蛋白与内源性LRRK2的结合丧失。[1] 在表达人类R1441C-和G2019S-LRRK2的转基因C. elegans中,LRRK2-IN1挽救了多巴胺能受损特有的行为缺陷。[2] 在小鼠成纤维细胞中,LRRK2-IN1降低了细胞移动性。[3] 在AsPC-1和HCT116细胞系中,LRRK2-IN-1显示出抗增殖和促凋亡属性,诱导G1和G2/M细胞周期阻滞,并抑制DCLK1 mRNA和蛋白表达。[4] |
体内活性 | 在野生型雄性C57BL/6小鼠中,LRRK2-IN-1(100 mg/kg,i.p.)抑制肾脏中LRRK2的Ser910和Ser935去磷酸化,而在大脑中无效果。[1] |
激酶实验 | IC50 determination: Active GST-LRRK2 (1326-2527), GST-LRRK2 [G2019S] (1326-2527), GST-LRRK2 [A2016T] (1326-2527) and GST-LRRK2 [A2016T+G2019S] (1326-2527) enzyme is purified with glutathione sepharose from HEK293 cell lysate 36 h following transient transfection of the appropriate cDNA constructs. Peptide kinase assays, performed in duplicate, are set up in a total volume of 40 μL containing 0.5 μg LRRK2 kinase (which at approximately 10% purity gives a final concentration of 8 nM) in 50 mM Tris/HCl, pH 7.5, 0.1 mM EGTA, 10 mM MgCl2, 20 μM Nictide, 0.1 μM [γ-32P]ATP (~500 cpm/pmol) and the indicated concentrations of inhibitor dissolved in DMSO. After incubation for 15 min at 30 °C, reactions are terminated by spotting 35 μL of the reaction mix onto P81 phosphocellulose paper and immersion in 50 mM phosphoric acid. Samples are washed extensively and the incorporation of [γ-32P]ATP into Nictide is quantified by Cerenkov counting. IC50 values are calculated with GraphPad Prism using non-linear regression analysis. |
细胞实验 | Cells are seeded into a 96-well tissue culture plate in triplicate. The cells are cultured in the presence of LRRK2-IN-1 with DMSO as a vehicle at 0, 0.31, 0.63, 1, 2, and 5, 10, and 20 μM. 48 h post treatment, 10 μL of TACS MTT Reagent (RND Systems) is added to each well and the cells are incubated at 37°C until dark crystalline precipitate became visible in the cells. 100 μL of 266 mM NH4OH in DMSO is then added to the wells and placed on a plate shaker at low speed for 1 minute. After shaking, the plate is allowed to incubate for 10 minutes protected from light and the OD550 for each well is read using a microplate reader. The results are averaged and calculated as a percentage of the DMSO (vehicle) control +/- the standard error of the mean.(Only for Reference) |
别名 | 5,11-二氢-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 |
分子量 | 570.69 |
分子式 | C31H38N8O3 |
CAS No. | 1234480-84-2 |
Smiles | COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1 |
密度 | 1.278 g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | Ethanol: 57 mg/mL (100 mM) DMSO: 45 mg/mL (78.85 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容